![Gregory Bonfiglio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Bonfiglio
Fondateur chez
Proteus RM LLC (Venture Capital)
Profil
Mr. Bonfiglio is the Founder & Managing Partner of Proteus, LLC.
Mr. Bonfiglio was an early investor in the field of stems cell & regenerative medicine, and he continues to actively invest in the field.
Proteus is raising a new early stage, venture fund focused exclusively on regenerative medicines.
Mr. Bonfiglio is the Chairman of the Board of the Centre for Commercialization of Regenerative Medicine, a RM Translation Center in Toronto, Canada.
He is a Member of the ISSCR and is on their Advisory Board, as well as their Finance Committee.
He also is a Member of the ISCT.
Mr. Bonfiglio has served on the Boards of several RM companies, including VistaGen Therapeutics (in vitro tools from hESCs); California Stem Cell (hESC tools & therapeutics); and StemCyte, Inc. (cord blood storage & therapeutics).
Mr. Bonfiglio is a frequent speaker at Regenerative Medicine Conferences.
In 2013, Mr. Bonfiglio was listed among the Top 50 Stem Cell Influencers in the world (Ranked 14th).
From 2000 – 2005, Mr. Bonfiglio was a General Partner with Anthem Venture Partners – an early stage venture fund in California.
Mr. Bonfiglio led Anthem’s investment in Advanced Cell Technology in 2000, and he helped take the Company public in 2005.
Mr. Bonfiglio also led Anthem’s investment in Corus Pharma, and helped engineer the sale of Corus to Gilead.
Prior to joining Anthem, Mr. Bonfiglio was a Partner with Morrison & Foerster, where he worked extensively with technology clients.
Mr. Bonfiglio was an Adjunct Professor of Law at Stanford Law School, from 1996 to 2000.
He has been a Guest Lecturer at the Stanford Business School on the Commercialization of RM Technologies.
From 1995 -2005, he was a regular Guest Lecturer at the UC Berkley Haas Business School in the Entrepreneurship Program.
Mr. Bonfiglio received his B.A. in Mathematics (magna cum laude) from Michigan State University in 1975, and his J.D.
(magna cum laude) from the University of Michigan Law School in 1981.
Postes actifs de Gregory Bonfiglio
| Sociétés | Poste | Début |
|---|---|---|
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM invests in companies located in the United States. The firm focuses on regenerative medicine, cell therapy, gene therapy, tissue engineering, bio-asethic medicine and underpinning technologies sectors. It provides financing for early stage capital requirements. | Fondateur | 01/01/2016 |
The International Society for Stem Cell Research
 The International Society for Stem Cell Research The International Society for Stem Cell Research is a company based in Deerfield, IL. | Corporate Officer/Principal | 25/06/2011 |
International Society for Cellular Therapy
 International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services Conducts cell-based research, processing, and manipulation, and publishes researched materials | Corporate Officer/Principal | 25/06/2011 |
NeoStem Oncology LLC
 NeoStem Oncology LLC Pharmaceuticals: MajorHealth Technology Develops human therapies based on human embryonic stem cells | Directeur/Membre du Conseil | 17/05/2012 |
ImmuneBridge, Inc.
 ImmuneBridge, Inc. BiotechnologyHealth Technology Develops allogeneic immunotherapies for cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Gregory Bonfiglio
| Sociétés | Poste | Fin |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/01/2013 |
Vistastem, Inc.
 Vistastem, Inc. BiotechnologyHealth Technology Develops embryonic stem cells for drug discovery and development | Directeur/Membre du Conseil | 10/06/2011 |
Excaliber Enterprises Ltd.
 Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Sells gift baskets via the Internet | Directeur/Membre du Conseil | 10/06/2011 |
Anthem Venture Management LLC
 Anthem Venture Management LLC Investment ManagersFinance Anthem Venture Management invests in companies located in the United States primarily in Southern California. The firm focuses on the technology sector. It participates in early stage capital requirements with an investment size of USD 1 –5 million and also makes co-investments. It acts as lead or co-lead investor and takes a seat on the board of directors. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Gregory Bonfiglio
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
StemCyte, Inc.
 StemCyte, Inc. Medical/Nursing ServicesHealth Services Provides baby’s precious stem cells preservation services | Health Services |
NeoStem Oncology LLC
NeoStem Oncology LLC Pharmaceuticals: MajorHealth Technology Develops human therapies based on human embryonic stem cells | Health Technology |
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Sells gift baskets via the Internet | Technology Services |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Vistastem, Inc.
Vistastem, Inc. BiotechnologyHealth Technology Develops embryonic stem cells for drug discovery and development | Health Technology |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services Conducts cell-based research, processing, and manipulation, and publishes researched materials | Commercial Services |
Anthem Venture Management LLC
Anthem Venture Management LLC Investment ManagersFinance Anthem Venture Management invests in companies located in the United States primarily in Southern California. The firm focuses on the technology sector. It participates in early stage capital requirements with an investment size of USD 1 –5 million and also makes co-investments. It acts as lead or co-lead investor and takes a seat on the board of directors. | Finance |
The International Society for Stem Cell Research
The International Society for Stem Cell Research The International Society for Stem Cell Research is a company based in Deerfield, IL. | |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM invests in companies located in the United States. The firm focuses on regenerative medicine, cell therapy, gene therapy, tissue engineering, bio-asethic medicine and underpinning technologies sectors. It provides financing for early stage capital requirements. | Finance |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
Proteus LLC
 Proteus LLC Investment ManagersFinance Provides investment and wealth advisory services | Finance |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Provides regenerative medicine-based technologies and cell and gene therapy | Health Technology |
Healios KK
 Healios KK Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of cell therapy and regenerative medicine products | Health Technology |
The University of Michigan Law School
 The University of Michigan Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmuneBridge, Inc.
ImmuneBridge, Inc. BiotechnologyHealth Technology Develops allogeneic immunotherapies for cancer | Health Technology |
